Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Acth (4-7), Pro-gly-pro-
2. Acth (4-7), Prolyl-glycyl-proline-
3. Pro-gly-pro-acth (4-7)
1. 80714-61-0
2. Acth (4-7), Pro-gly-pro-
3. Mehfpgp
4. Met-glu-his-phe-pro-gly-pro
5. I5fal2585h
6. Acth (4-7), Prolyl-glycyl-proline-
7. Pro-gly-pro-acth (4-7)
8. Unii-i5fal2585h
9. L-methionyl-l-alpha-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-l-proline
10. (2s)-1-[2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic Acid
11. L-proline, 1-(n-(1-(n-(n-(n-l-methionyl-l-alpha-glutamyl)-l-histidyl)-l-phenylalanyl)-l-prolyl)glycyl)-
12. Semax?
13. H-met-glu-his-phe-pro-gly-pro-oh
14. Schembl7200319
15. Glxc-25922
16. Hy-p1146
17. Akos040744795
18. At42448
19. Da-77788
20. Met-glu-his-phe-pro-gly-pro [who-dd]
21. Cs-0028296
22. Methionyl-glutamyl-histidyl-phenylalanyl-prolyl-glycyl-proline
23. L-proline, L-methionyl-l-.alpha.-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-
24. L-proline, L-methionyl-l-alpha-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-
Molecular Weight | 813.9 g/mol |
---|---|
Molecular Formula | C37H51N9O10S |
XLogP3 | -2.8 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 21 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 312 |
Heavy Atom Count | 57 |
Formal Charge | 0 |
Complexity | 1450 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
Nootropic Agents
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)
ABOUT THIS PAGE
22
PharmaCompass offers a list of Semax API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Semax manufacturer or Semax supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Semax manufacturer or Semax supplier.
PharmaCompass also assists you with knowing the Semax API Price utilized in the formulation of products. Semax API Price is not always fixed or binding as the Semax Price is obtained through a variety of data sources. The Semax Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Semax manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Semax, including repackagers and relabelers. The FDA regulates Semax manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Semax API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Semax manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Semax supplier is an individual or a company that provides Semax active pharmaceutical ingredient (API) or Semax finished formulations upon request. The Semax suppliers may include Semax API manufacturers, exporters, distributors and traders.
click here to find a list of Semax suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Semax as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Semax API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Semax as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Semax and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Semax NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Semax suppliers with NDC on PharmaCompass.
Semax Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Semax GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Semax GMP manufacturer or Semax GMP API supplier for your needs.
A Semax CoA (Certificate of Analysis) is a formal document that attests to Semax's compliance with Semax specifications and serves as a tool for batch-level quality control.
Semax CoA mostly includes findings from lab analyses of a specific batch. For each Semax CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Semax may be tested according to a variety of international standards, such as European Pharmacopoeia (Semax EP), Semax JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Semax USP).